BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 31532171)

  • 1. [Control and prevention of kidney transplant rejection: the role and possibilities for the clinical use of regulatory T-cells in transplantation].
    Mukhin VE; Polyakova YV; Kaabak MM; Babenko NN; Bryzgalina EV; V'yunkova YN
    Khirurgiia (Mosk); 2019; (9):80-85. PubMed ID: 31532171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell Therapy in Kidney Transplantation: Focus on Regulatory T Cells.
    Zwang NA; Leventhal JR
    J Am Soc Nephrol; 2017 Jul; 28(7):1960-1972. PubMed ID: 28465379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of regulatory T cells on short-term graft outcome in kidney transplant recipients, a prospective observational, single-center study.
    Bejugama K; Taduri G; Guditi S
    Transpl Immunol; 2022 Aug; 73():101630. PubMed ID: 35643376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kidney transplantation: a safe step forward for regulatory immune cell therapy.
    Thomson AW; Tevar AD
    Lancet; 2020 May; 395(10237):1589-1591. PubMed ID: 32446400
    [No Abstract]   [Full Text] [Related]  

  • 5. Regulatory T-cell therapy in transplantation: moving to the clinic.
    Tang Q; Bluestone JA
    Cold Spring Harb Perspect Med; 2013 Nov; 3(11):. PubMed ID: 24186492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
    Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
    Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility, long-term safety, and immune monitoring of regulatory T cell therapy in living donor kidney transplant recipients.
    Harden PN; Game DS; Sawitzki B; Van der Net JB; Hester J; Bushell A; Issa F; Brook MO; Alzhrani A; Schlickeiser S; Scotta C; Petchey W; Streitz M; Blancho G; Tang Q; Markmann J; Lechler RI; Roberts ISD; Friend PJ; Hilton R; Geissler EK; Wood KJ; Lombardi G
    Am J Transplant; 2021 Apr; 21(4):1603-1611. PubMed ID: 33171020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory T cells in kidney disease and transplantation.
    Hu M; Wang YM; Wang Y; Zhang GY; Zheng G; Yi S; O'Connell PJ; Harris DC; Alexander SI
    Kidney Int; 2016 Sep; 90(3):502-14. PubMed ID: 27263492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Pursuit of Regulatory T Cells in the Induction of Transplant Tolerance.
    Arnold PR; Li XC
    Adv Exp Med Biol; 2021; 1278():273-287. PubMed ID: 33523453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Humoral immunity and kidney transplantation. Possibilities and desensitizing treatment].
    Rowshani AT; Lardy NM; Surachno JS; ten Berge RJ
    Ned Tijdschr Geneeskd; 2009 Mar; 153(13):612-6. PubMed ID: 19408538
    [No Abstract]   [Full Text] [Related]  

  • 11. The impact of induction therapy on the homeostasis and function of regulatory T cells in kidney transplant patients.
    Bouvy AP; Klepper M; Kho MM; Boer K; Betjes MG; Weimar W; Baan CC
    Nephrol Dial Transplant; 2014 Aug; 29(8):1587-97. PubMed ID: 24771499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory T cells in kidney transplant recipients: the effect of induction immunosuppression therapy.
    Krystufkova E; Sekerkova A; Striz I; Brabcova I; Girmanova E; Viklicky O
    Nephrol Dial Transplant; 2012 Jun; 27(6):2576-82. PubMed ID: 22167587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low circulating regulatory T-cell levels after acute rejection in liver transplantation.
    Demirkiran A; Kok A; Kwekkeboom J; Kusters JG; Metselaar HJ; Tilanus HW; van der Laan LJ
    Liver Transpl; 2006 Feb; 12(2):277-84. PubMed ID: 16447185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased degradation of ATP is driven by memory regulatory T cells in kidney transplantation tolerance.
    Durand M; Dubois F; Dejou C; Durand E; Danger R; Chesneau M; Brosseau C; Guerif P; Soulillou JP; Degauque N; Eliaou JF; Giral M; Bonnefoy N; Brouard S
    Kidney Int; 2018 May; 93(5):1154-1164. PubMed ID: 29455908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory T cells: first steps of clinical application in solid organ transplantation.
    van der Net JB; Bushell A; Wood KJ; Harden PN
    Transpl Int; 2016 Jan; 29(1):3-11. PubMed ID: 25981203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and Basic Research Progress on Treg-Induced Immune Tolerance in Liver Transplantation.
    Ni X; Wang Q; Gu J; Lu L
    Front Immunol; 2021; 12():535012. PubMed ID: 34093514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treg therapy in transplantation: a general overview.
    Romano M; Tung SL; Smyth LA; Lombardi G
    Transpl Int; 2017 Aug; 30(8):745-753. PubMed ID: 28012226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory T cells in transplantation.
    Wood KJ
    Transplant Proc; 2011; 43(6):2135-6. PubMed ID: 21839214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sirolimus vs cyclosporine after induction with basiliximab does not promote regulatory T cell expansion in de novo kidney transplantation: Results from a single-center randomized trial.
    Libetta C; Esposito P; Gregorini M; Margiotta E; Martinelli C; Borettaz I; Canevari M; Rampino T; Ticozzelli E; Abelli M; Meloni F; Dal Canton A
    Transpl Immunol; 2015 Oct; 33(2):117-24. PubMed ID: 26220254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of CD4
    McRae JL; Chia JS; Pommey SA; Dwyer KM
    Nephrology (Carlton); 2017 Jul; 22(7):505-512. PubMed ID: 27517975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.